EUVIMEDEUVIMED entdecken
Crossref

Comparison between Intravenous and Perineural Dexmedetomidine in Enhancing the Block Effect of Ultrasound-Guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries

Susantika Kundu, Smita D. Patil, S. B. Gangadhar

International Journal of Current Pharmaceutical Review and Research · 11.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.43 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 11.03.2026. Verfasst von Susantika Kundu und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ultrasound-guided supraclavicular brachial plexus block (SCBPB) is widely used for upper limb surgeries because it provides excellent intraoperative anesthesia and postoperative analgesia. Local anesthetics such as bupivacaine are commonly used; however, their duration of action may be limited. Dexmedetomidine, a highly selective α2-adrenergic agonist, has gained popularity as an adjuvant to local anesthetics in peripheral nerve blocks due to its sedative, analgesic, and sympatholytic properties. Dexmedetomidine can be administered either intravenously or perineurally, but the optimal route of administration remains a subject of ongoing research.

Aim

To compare the efficacy of perineural versus intravenous dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided supraclavicular brachial plexus block in patients undergoing upper limb surgeries. Materials and Methods: This longitudinal comparative study was conducted at Sri Siddhartha Medical College and Hospital, Tumkur, Karnataka, India, over a period of 24 months. A total of 70 patients scheduled for elective upper limb surgeries under ultrasound-guided supraclavicular brachial plexus block were included in the study. Patients were randomly divided into two equal groups (n = 35 each). Group I (Intravenous group) received Inj. Bupivacaine 0.5% plain 20 mL perineurally with Inj. Dexmedetomidine 1 µg/kg administered intravenously. Group P (Perineural group) received Inj. Bupivacaine 0.5% plain 20 mL with Inj. Dexmedetomidine 1 µg/kg administered perineurally. Parameters assessed included onset and duration of sensory and motor block, duration of analgesia, hemodynamic variables, sedation scores, and adverse effects.

Results

Perineural dexmedetomidine significantly prolonged the duration of sensory and motor blockade compared with intravenous dexmedetomidine (p

Zitieren

APA

Kundu, S., Patil, S. D., & Gangadhar, S. B. (2026). Comparison between Intravenous and Perineural Dexmedetomidine in Enhancing the Block Effect of Ultrasound-Guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.43

Vancouver

Kundu S, Patil SD, Gangadhar SB. Comparison between Intravenous and Perineural Dexmedetomidine in Enhancing the Block Effect of Ultrasound-Guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.43

BibTeX
@article{Kundu2026,
  author = {Kundu, Susantika and Patil, Smita D. and Gangadhar, S. B.},
  title = {Comparison between Intravenous and Perineural Dexmedetomidine in Enhancing the Block Effect of Ultrasound-Guided Supraclavicular Brachial Plexus Block in Upper Limb Surgeries},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.43}
}
Kostenlos starten →